Aldeyra Therapeutics (ALDX)
Develops RASP modulators and ophthalmology candidates for immune-mediated diseases.
$1.35
vs last close−0.04 (−3.23%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 42 days
EPS estimate
−$0.11
Revenue estimate
$2.5M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.27−$0.17−$0.16−$0.13−$0.11−$0.06−$0.09Pending
Estimate−$0.25−$0.25−$0.21−$0.17−$0.14−$0.13−$0.09−$0.11
Surprise−8.0%+32.0%+23.8%+23.5%+21.4%+53.8%−2.9%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$244.5K——————Pending
Estimate—−$666.7K—$24.3M$4.8M—$31.3M$2.5M
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.08 | — | — |
| Sep 2027 | −$0.08 | — | — |
| Jun 2027 | −$0.08 | — | — |
| Mar 2027 | −$0.06 | — | — |
| Dec 2026 | −$0.10 | — | — |
| Nov 2026 | −$0.11 | — | — |
| Aug 2026 | −$0.09 | −$0.09 | −2.9% |
| May 2026 | −$0.13 | −$0.06 | +53.8% |
| Feb 2026 | −$0.14 | −$0.11 | +21.4% |
| Nov 2025 | −$0.17 | −$0.13 | +23.5% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Oct 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.08 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.08 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.08 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.06 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.10 | — | — | $0 | — | — | — |
| Nov 4, 2026 | −$0.11 | — | — | $2.5M | — | — | — |
| Aug 6, 2026 | −$0.09 | −$0.09 | −2.9% | $31.3M | — | — | −0.6% |
| May 7, 2026 | −$0.13 | −$0.06 | +53.8% | — | — | — | 0.0% |
| Feb 27, 2026 | −$0.14 | −$0.11 | +21.4% | $4.8M | — | — | +2.9% |
| Nov 5, 2025 | −$0.17 | −$0.13 | +23.5% | $24.3M | — | — | +0.2% |
| Aug 7, 2025 | |||||||
| May 14, 2025 | |||||||
| Feb 28, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 2, 2024 | |||||||
| Mar 7, 2024 | |||||||
| Nov 3, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 5, 2022 | |||||||
| May 5, 2022 | |||||||
| Mar 17, 2022 | |||||||
| Oct 28, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 11, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 12, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 8, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 15, 2018 | |||||||
| Mar 29, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 15, 2017 | |||||||
| Mar 30, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 10, 2016 | |||||||
| May 9, 2016 | |||||||
| Mar 30, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 11, 2015 |